Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.
Rapid Dose Therapeutics Corp. (RDT) is set to enhance its financial stability and fund expansion through a private placement financing aimed at raising $6 million and a debt settlement deal involving the issuance of common shares to creditors. These strategic moves are designed to retire debt, bolster research and development, and provide necessary working capital. The initiatives also align with RDT’s commitment to advancing its QuickStrip™ drug delivery technology, promising rapid onset of active ingredients into the bloodstream.
For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.
